Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Wien Med Wochenschr ; 159(1-2): 40-6, 2009.
Artigo em Alemão | MEDLINE | ID: mdl-19225734

RESUMO

A total number of 3,260 smokers were included into a 4-week smoking cessation programme of the Regional Sickness Fund of Lower Austria in which participants were coached by health care professionals. The smoking status of each subject, as determined by measuring expired CO, resulted in a success rate of 70.6% (non-smokers and persons with smoking reduction). Success rates were emerged to increase with decreasing level of baseline nicotine dependence (determined with the Fagerström Test for Nicotine Dependence = FTND). Even in the group of heavily dependent smokers, however, (FTND Score 8-10) a non-smoking rate of 33.9% was achieved. Moreover, an additional 27.6% of the persons of this group had reduced the number of cigarettes smoked daily. The positive effect of nicotine replacement therapy (NRT) could be demonstrated by the high rate of 69.3% non-smokers in this group of participants, which was clearly higher than in participants who did not use NRT.


Assuntos
Nicotina/administração & dosagem , Abandono do Hábito de Fumar/métodos , Prevenção do Hábito de Fumar , Tabagismo/diagnóstico , Tabagismo/terapia , Administração por Inalação , Administração Sublingual , Adulto , Testes Respiratórios , Monóxido de Carbono/análise , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nicotina/uso terapêutico , Comprimidos , Fatores de Tempo , Resultado do Tratamento
2.
Wien Med Wochenschr ; 159(1-2): 47-52, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19225735

RESUMO

AIMS: To study nocturnal sleep-disturbing nicotine craving (NSDNC), described as a symptom of nicotine dependence, in 2884 patients. METHODS: All patients were part of a smoking cessation program of the Nicotine Institute in collaboration with the general sick fund of Lower Austria. During the study period, the program (which is ongoing) lasted five weeks and included individual counseling. At all appointments, patients received a questionnaire about smoking habits, illnesses, previous experience in smoking cessation and their motivation to complete the program with the help of an assistant. Carbon monoxide levels in expired air were also measured. RESULTS: Analysis of NSDNC showed that 22.4% (n = 647) of patients suffered from this symptom with varying intensity: 77.1% (n = 499) awoke rarely; 9.4% (n = 61) awoke several times per week; 6.8% (n = 44) awoke most days and 6.6% (n = 43) awoke daily. NSDNC was associated with nicotine dependence, the number of cigarettes smoked per day, CO level and the craving for cigarettes in general. Consequences for smoking cessation programs are complex. Success rates were influenced by the intensity of NSDNC. Patients who awoke most days or daily had the lowest chance to quit smoking and the lowest compliance with the program. CONCLUSIONS: Patients suffering from NSDNC, especially those who awoke most days or daily, formed a specific group among cigarette smokers. They can be classified as highly dependent smokers who have special needs regarding treatment strategies and medication. Further developments of specific cessation programs and strategies of tobacco harm reduction are recommended.


Assuntos
Terapia Comportamental , Bupropiona/uso terapêutico , Nicotina/administração & dosagem , Transtornos do Sono-Vigília/etiologia , Abandono do Hábito de Fumar/métodos , Tabagismo/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Testes Respiratórios , Bupropiona/administração & dosagem , Monóxido de Carbono/análise , Distribuição de Qui-Quadrado , Criança , Aconselhamento , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nicotina/uso terapêutico , Inquéritos e Questionários , Fatores de Tempo , Tabagismo/complicações , Tabagismo/diagnóstico , Tabagismo/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA